205 related articles for article (PubMed ID: 19609101)
1. A shift from nuclear to cytoplasmic breast cancer metastasis suppressor 1 expression is associated with highly proliferative estrogen receptor-negative breast cancers.
Frolova N; Edmonds MD; Bodenstine TM; Seitz R; Johnson MR; Feng R; Welch DR; Frost AR
Tumour Biol; 2009; 30(3):148-59. PubMed ID: 19609101
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival.
Slipicevic A; Holm R; Emilsen E; Ree Rosnes AK; Welch DR; Mælandsmo GM; Flørenes VA
BMC Cancer; 2012 Feb; 12():73. PubMed ID: 22356677
[TBL] [Abstract][Full Text] [Related]
3. Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer.
Zhang Z; Yamashita H; Toyama T; Yamamoto Y; Kawasoe T; Iwase H
Clin Cancer Res; 2006 Nov; 12(21):6410-4. PubMed ID: 17085653
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis.
Li J; Cheng Y; Tai D; Martinka M; Welch DR; Li G
Oncogene; 2011 Feb; 30(8):896-906. PubMed ID: 20935672
[TBL] [Abstract][Full Text] [Related]
5. The C-terminal putative nuclear localization sequence of breast cancer metastasis suppressor 1, BRMS1, is necessary for metastasis suppression.
Hurst DR; Xie Y; Thomas JW; Liu J; Edmonds MD; Stewart MD; Welch DR
PLoS One; 2013; 8(2):e55966. PubMed ID: 23390556
[TBL] [Abstract][Full Text] [Related]
6. Loss of breast cancer metastasis suppressor 1 protein expression predicts reduced disease-free survival in subsets of breast cancer patients.
Hicks DG; Yoder BJ; Short S; Tarr S; Prescott N; Crowe JP; Dawson AE; Budd GT; Sizemore S; Cicek M; Choueiri TK; Tubbs RR; Gaile D; Nowak N; Accavitti-Loper MA; Frost AR; Welch DR; Casey G
Clin Cancer Res; 2006 Nov; 12(22):6702-8. PubMed ID: 17121889
[TBL] [Abstract][Full Text] [Related]
7. [Expression and clinical significance of LRP16 gene in human breast cancer].
Liao DX; Han WD; Zhao YL; Pu YD; Mu YM; Luo CH; Li XH
Ai Zheng; 2006 Jul; 25(7):866-70. PubMed ID: 16831279
[TBL] [Abstract][Full Text] [Related]
8. Nuclear location of tumor suppressor protein maspin inhibits proliferation of breast cancer cells without affecting proliferation of normal epithelial cells.
Machowska M; Wachowicz K; Sopel M; Rzepecki R
BMC Cancer; 2014 Feb; 14():142. PubMed ID: 24581141
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic localization of alteration/deficiency in activation 3 (ADA3) predicts poor clinical outcome in breast cancer patients.
Mirza S; Rakha EA; Alshareeda A; Mohibi S; Zhao X; Katafiasz BJ; Wang J; Gurumurthy CB; Bele A; Ellis IO; Green AR; Band H; Band V
Breast Cancer Res Treat; 2013 Feb; 137(3):721-31. PubMed ID: 23288344
[TBL] [Abstract][Full Text] [Related]
10. Gli1 promotes cell survival and is predictive of a poor outcome in ERalpha-negative breast cancer.
Xu L; Kwon YJ; Frolova N; Steg AD; Yuan K; Johnson MR; Grizzle WE; Desmond RA; Frost AR
Breast Cancer Res Treat; 2010 Aug; 123(1):59-71. PubMed ID: 19902354
[TBL] [Abstract][Full Text] [Related]
11. Expression of breast cancer metastasis suppressor-1, BRMS-1, in human breast cancer and the biological impact of BRMS-1 on the migration of breast cancer cells.
Zhang Y; Ye L; Tan Y; Sun P; Ji K; Jiang WG
Anticancer Res; 2014 Mar; 34(3):1417-26. PubMed ID: 24596389
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity.
Cicek M; Fukuyama R; Welch DR; Sizemore N; Casey G
Cancer Res; 2005 May; 65(9):3586-95. PubMed ID: 15867352
[TBL] [Abstract][Full Text] [Related]
13. A Ki67/BCL2 index based on immunohistochemistry is highly prognostic in ER-positive breast cancer.
Ali HR; Dawson SJ; Blows FM; Provenzano E; Leung S; Nielsen T; Pharoah PD; Caldas C
J Pathol; 2012 Jan; 226(1):97-107. PubMed ID: 21953021
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer metastasis suppressor-1 promoter methylation in primary breast tumors and corresponding circulating tumor cells.
Chimonidou M; Kallergi G; Georgoulias V; Welch DR; Lianidou ES
Mol Cancer Res; 2013 Oct; 11(10):1248-57. PubMed ID: 23744981
[TBL] [Abstract][Full Text] [Related]
15. Expression of the breast cancer metastasis suppressor gene, BRMS1, in human breast carcinoma: lack of correlation with metastasis to axillary lymph nodes.
Kelly LM; Buggy Y; Hill A; O'Donovan N; Duggan C; McDermott EW; O'Higgins NJ; Young L; Duffy MJ
Tumour Biol; 2005; 26(4):213-6. PubMed ID: 16006775
[TBL] [Abstract][Full Text] [Related]
16. Low BRMS1 expression promotes nasopharyngeal carcinoma metastasis in vitro and in vivo and is associated with poor patient survival.
Cui RX; Liu N; He QM; Li WF; Huang BJ; Sun Y; Tang LL; Chen M; Jiang N; Chen L; Yun JP; Zeng J; Guo Y; Wang HY; Ma J
BMC Cancer; 2012 Aug; 12():376. PubMed ID: 22931099
[TBL] [Abstract][Full Text] [Related]
17. Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer.
Brennan DJ; Rexhepaj E; O'Brien SL; McSherry E; O'Connor DP; Fagan A; Culhane AC; Higgins DG; Jirstrom K; Millikan RC; Landberg G; Duffy MJ; Hewitt SM; Gallagher WM
Clin Cancer Res; 2008 May; 14(9):2681-9. PubMed ID: 18451232
[TBL] [Abstract][Full Text] [Related]
18. Piwil2 is expressed in various stages of breast cancers and has the potential to be used as a novel biomarker.
Liu JJ; Shen R; Chen L; Ye Y; He G; Hua K; Jarjoura D; Nakano T; Ramesh GK; Shapiro CL; Barsky SH; Gao JX
Int J Clin Exp Pathol; 2010 Mar; 3(4):328-37. PubMed ID: 20490325
[TBL] [Abstract][Full Text] [Related]
19. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer metastasis suppressor gene, breast cancer metastasis suppressor 1, may be associated with clinicopathological features of breast cancer.
Lin L; Cai M; Dai Y; Zheng Z; Jiang F; Shi L; Pan Y; Song HB
J Cancer Res Ther; 2018 Jun; 14(Supplement):S368-S374. PubMed ID: 29970691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
